152 related articles for article (PubMed ID: 3875403)
1. Isolation of mouse T-cell lymphoma lines from different long-term interleukin 2-dependent cultures.
Giglia JS; Ovak GM; Yoshida MA; Twist CJ; Jeffery AR; Pauly JL
Cancer Res; 1985 Oct; 45(10):5027-34. PubMed ID: 3875403
[TBL] [Abstract][Full Text] [Related]
2. Leukemic cells arise from cloned cytotoxic lymphocytes during cell culture.
Simon MM; Ali S; Tewari R; Simon HG; Müller-Hermelink HK; Epplen JT
Eur J Immunol; 1986 Oct; 16(10):1269-76. PubMed ID: 3095125
[TBL] [Abstract][Full Text] [Related]
3. Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X.
Lasky JL; Ponzio NM; Thorbecke GJ
J Immunol; 1988 Jan; 140(2):679-87. PubMed ID: 3275720
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and biologic characterization of lymphocyte regulatory molecules. III. The isolation and phenotypic characterization of Interleukin-2 producing T cell lymphomas.
Gillis S; Scheid M; Watson J
J Immunol; 1980 Dec; 125(6):2570-8. PubMed ID: 6968790
[TBL] [Abstract][Full Text] [Related]
5. Formation of an active form of the interleukin-2/15 receptor beta-chain by insertion of the intracisternal A particle in a radiation-induced mouse thymic lymphoma and its role in tumorigenesis.
Ukai H; Ishii-Oba H; Ukai-Tadenuma M; Ogiu T; Tsuji H
Mol Carcinog; 2003 Jun; 37(2):110-9. PubMed ID: 12766910
[TBL] [Abstract][Full Text] [Related]
6. The same cloned murine B lymphoma cell lines can be selectively induced to release either interleukin-1- or interleukin-2-like factor activity.
Walker EB; Leemhuis T
Lymphokine Res; 1987; 6(2):71-81. PubMed ID: 3495708
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the antigen-reactive T cell line mediating in vivo delayed type hypersensitivity established by antigen-induced interleukin 2.
Kobayashi K; Cohen S; Yoshida T
J Exp Pathol; 1989; 4(3):163-79. PubMed ID: 2788724
[TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptor vIII enhances tumorigenicity in human breast cancer.
Tang CK; Gong XQ; Moscatello DK; Wong AJ; Lippman ME
Cancer Res; 2000 Jun; 60(11):3081-7. PubMed ID: 10850460
[TBL] [Abstract][Full Text] [Related]
9. Human T-cell leukemia virus type 2 Tax protein induces interleukin 2-independent growth in a T-cell line.
Kondo R; Higuchi M; Takahashi M; Oie M; Tanaka Y; Gejyo F; Fujii M
Retrovirology; 2006 Dec; 3():88. PubMed ID: 17140451
[TBL] [Abstract][Full Text] [Related]
10. Phorbol myristate acetate-stimulated production of interleukin 2 by T-cell lymphoma and constitutive production by derived hybridomas.
Bubeník J; Indrová M; Símová J; Kypĕnová H; Bubeníková D; Dolezalová K
Neoplasma; 1984; 31(5):497-505. PubMed ID: 6334241
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 2 administered in vivo induces the growth of cultured T cells in vivo.
Cheever MA; Greenberg PD; Irle C; Thompson JA; Urdal DL; Mochizuki DY; Henney CS; Gillis S
J Immunol; 1984 May; 132(5):2259-65. PubMed ID: 6609193
[TBL] [Abstract][Full Text] [Related]
12. Lack of adenosine deaminase activity in cultured murine cytotoxic T lymphocytes.
Minkowski MD; Castellazzi M; Buttin G
J Immunol; 1984 Jul; 133(1):52-8. PubMed ID: 6609994
[TBL] [Abstract][Full Text] [Related]
13. Effector mechanisms of syngeneic anti-tumour responses in mice. I. Establishment and characterization of an exogenous IL-2-independent cytotoxic T-lymphocyte line specific for radiation-induced leukaemia RL male 1.
Kuribayashi K; Keyaki A; Sakaguchi S; Masuda T
Immunology; 1985 Sep; 56(1):127-40. PubMed ID: 3876271
[TBL] [Abstract][Full Text] [Related]
14. Evidence for specific receptors for interleukin 3 on lymphokine-dependent cell lines established from long-term bone marrow cultures.
Palaszynski EW; Ihle JN
J Immunol; 1984 Apr; 132(4):1872-8. PubMed ID: 6421927
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 2 enhancement of lymphokine secretion by T lymphocytes: analysis of established clones and primary limiting dilution microcultures.
Kelso A; MacDonald HR; Smith KA; Cerottini JC; Brunner KT
J Immunol; 1984 Jun; 132(6):2932-8. PubMed ID: 6233365
[TBL] [Abstract][Full Text] [Related]
16. Characterization of a novel malignant B cell line with t(14;18) and t(4;11) established from a patient with acute monoblastic leukemia.
de Kroon JF; Kluin-Nelemans HC; Kluin PM; Schuuring E; van Bergen CA; Oving I; Wessels H; Willemze R; Falkenburg JH
Exp Hematol; 1997 Sep; 25(10):1062-8. PubMed ID: 9293903
[TBL] [Abstract][Full Text] [Related]
17. Biology and biochemistry of T cell-derived lymphokines. I. The coordinate synthesis of interleukin 2 and colony-stimulating factors in a murine T cell lymphoma.
Watson JD
J Immunol; 1983 Jul; 131(1):293-7. PubMed ID: 6602832
[TBL] [Abstract][Full Text] [Related]
18. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
[TBL] [Abstract][Full Text] [Related]
19. Continuous cytotoxic T cell lines reactive against murine plasmacytoma tumor-associated antigens.
Giorgi JV; Warner NL
J Immunol; 1981 Jan; 126(1):322-30. PubMed ID: 6161166
[TBL] [Abstract][Full Text] [Related]
20. Retroviral transduction of protein kinase C-gamma into tumor-specific T cells allows antigen-independent long-term growth in IL-2 with retention of functional specificity in vitro and ability to mediate tumor therapy in vivo.
Chen W; Schweins E; Chen X; Finn OJ; Cheever MA
J Immunol; 1994 Oct; 153(8):3630-8. PubMed ID: 7930583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
